 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 05, 2023 GLOBE NEWSWIRE -- MannKind Corporation Nasdaq: MNKD a company focused on the development and commercialization of innovative therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will present at the 2023 Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:15 AM PST at the Westin St. Francis Hotel in San Francisco, California. 